Watch Ticker

Cingulate Inc. Common Stock

Go to Cingulate Inc. Common Stock Website

$5.39

0.29 (5.71%)

Live

Previous Close

$5.61

Day Range

$4.8502 - $5.74

Previous Day Range

$4.8 - $5.14

Market Cap

$26.2 million USD

Day Vol.

162969

Previous Day Vol.

64182

Currency

USD

Primary Exchange

Nasdaq

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Allarity Therapeutics - Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Allarity Therapeutics announced the appointment of Jeff Ervin as its new Chief Financial Officer, succeeding Alexander Epshinsky. Ervin brings nearly two decades of executive leadership experience in healthcare and biotech sectors, and will support the company's clinical development of stenoparib, a cancer treatment drug.

Related tickers: ALLR, BACK, CING, CINGW.

Read Full Article

N/A - Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved

Cingulate Inc. reported positive results for its lead ADHD asset CTx-1301, including successful completion of Phase 3 trials and plans to submit a New Drug Application in mid-2025. The company also strengthened its balance sheet through various financing activities.

Related tickers: CING, CINGW.

Read Full Article

Trending Tickers

Please sign in to view